Aspirin not always best treatment for many individuals

Coated aspirin tablets. Image: Wikimedia Commons.

(Medical Xpress)—An aspirin a day may not always keep heart disease away, say two University of Florida cardiologists. But a new algorithm they have developed outlines factors physicians should weigh as they assess whether a patient would benefit from a daily dose of the drug.

Approximately 50 million people in the United States pop a daily pill to treat or prevent heart disease. Of these, at least half take more than 100 milligrams of the drug—more than one baby aspirin—a day. Although aspirin has been widely used in over the past 20 to 30 years, a review of research papers suggests that the widely used over-the-counter medicine does not benefit everyone to the same degree, report Dr. Ki Park and Dr. Anthony A. Bavry in the May issue of Cleveland Clinic Journal of Medicine.

"Not all patients with are the same," said Park, a physician in the department of medicine's division of cardiovascular medicine.

Park and Bavry's algorithm leads physicians through a series of questions that consider the patient's age, sex and current health status. The answers help them determine whether the course of care should include aspirin.

"It's an evolving assessment that should be repeated every few years as conditions change," Park said.

Most studies on the effects of in patients who had previous heart attacks have focused on men. While examining the literature, Park and Bavry found that less is known about the effects of aspirin on women, people with diabetes, the elderly and even patients who are at risk of a but have never had one.

"In this paper we highlight gaps in knowledge where we don't fully know if aspirin should be used or not," said Bavry, an assistant professor of cardiovascular medicine. "There's still room to study its optimal use."

While people may see aspirin as a harmless drug, taking a daily aspirin does carry some risk of side effects such as gastrointestinal bleeding. Park and Bavry's review contains an analysis to help physicians determine whether the risks outweigh the benefits.

Their review showed that while aspirin therapy remains a good way to prevent further heart attacks, more is not better. A low-dose aspirin, such as an 81-milligram pill, gives the same amount of protection as a standard dose of 325 milligrams and lowers the risk of bleeding.

But even at a lower dose, the current literature suggests certain patients may not benefit from aspirin therapy. In women, for instance, evidence shows aspirin can help prevent certain types of stroke, but does not appear to prevent heart attacks as effectively as it does in men. On the other hand, women appear to have a lower risk of than men do.

Risk factors also change with age and the estimated 10-year risk for . The rise in use of cholesterol-lowering drugs called statins also can affect whether a patient should take aspirin. And aspirin therapy for with diabetes, who are automatically considered to be at high risk for cardiovascular disease, remains controversial.

"A lot goes in to estimating a patient's risk," Bavry said.

Related Stories

Aspirin may lower melanoma risk

Mar 11, 2013

A new study has found that women who take aspirin have a reduced risk of developing melanoma—and that the longer they take it, the lower the risk. The findings suggest that aspirin's anti-inflammatory effects may help protect ...

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

Oct 24, 2014

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments